Deadline :
30/11/99Reference number :
TOCVG/STR/990419/3
Production of recombinant proteins by eukaryotic cells (Vegetal and animal cells)
|
Deadline : 30/11/99Reference number : TOCVG/STR/990419/3 |
|
|
|
|
ABSTRACT |
|
Production of recombinant proteins for therapeutic uses, such as human growth hormone (HGH), interferons, interleukin, glyco-proteins (production of vaccines and medecines). The system of cell stress promotor technology is used. |
TECHNOLOGY DESCRIPTION
|
Opportunity type : |
Current stage of development :Available for demonstration |
|
Property rights : Patents granted : world patents, FDA agreement for a particular medecine |
|
|
Innovative aspects : This is a new production method using eukaryotic cells |
|
TECHNOLOGY APPLICATIONS
|
Concerned sectors : Biological sciences Biotechnology Medecine, health Pharmaceutical/cosmetics Veterinary |
Market applications : Medecines production Manufacturing companies |
|
Main competitive advantages : The proteins obtained are of high purity The production costs are low The system has been demonstrated at industrial scale on a bovine vaccine manufacture and is under development for human growth hormone production |
|
PARTNER SEARCHED
|
Contacts or collaborations : Licence agreement |
Countries : |
Keywords :
Production, recombinant proteins, eukaryotic systems+
contact : NORTHERN FRANCE INNOVATION RELAY CENTERCVG Philippe David
33, avenue Paul Claudel F-80480 Dury
( 33 (0)3 22 33 75 00 2 33 (0)3 22 33 75 01
-
cvgpn@wanadoo.fr http://www.cvgpn.comMise à jour le 26 août 1999 |
| ||||||
